title: Comparison of the efficacy of recombinant human brain natriuretic peptide with saline hydration in preventing contrast-induced nephropathy in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
abstract: The incidence of contrast-induced nephropathy has an increasing trend as a result of increased use of contrast media during coronary interventional procedures. Contrast-induced nephropathy is one of the major causes for hospital acquired renal failure after coronary interventional procedures. In this study, a total of 126 enrolled patients undergoing elective coronary angiography and/or percutaneous coronary intervention were randomly divided into two groups to investigate the efficacy of recombinant human brain natriuretic peptide in preventing contrast-induced nephropathy in patients undergoing elective coronary angiography and/or percutaneous coronary intervention. Our results showed that there was no statistically significant difference in the primary end points, with similar incidence of contrast-induced nephropathy in the two groups (P=0.770). In compared with the hydration group, the elevation of serum creatinine in the recombinant human brain natriuretic peptide group was less, especially at 48 hours (P=0.047) and at 72 hours (P=0.048) after the procedure. The creatinine clearance from baseline to 72 hours after the procedure was higher in the BNP group than in the hydration group. There were significant differences in creatinine clearance at 48 hours (P=0.016) and at 72 hours (P=0.019) between the two groups. In spite of similar incidence of contrast-induced nephropathy, recombinant human brain natriuretic peptide has its advantages for the protection of the renal function associated with better protection of renal function in patients undergoing elective coronary angiography and/or percutaneous coronary intervention, compared with saline hydration.
authors.affiliation: Department of Cardiac, The Fourth Affiliated Hospital of Harbin Medical University Harbin, China.
authors.forename: Chaoyu
authors.initials: C
authors.lastname: Sun
authors.affiliation: Department of Cardiac, The Fourth Affiliated Hospital of Harbin Medical University Harbin, China.
authors.forename: Jixin
authors.initials: J
authors.lastname: Zhi
authors.affiliation: Department of Cardiac, The Fourth Affiliated Hospital of Harbin Medical University Harbin, China.
authors.forename: Xiaopeng
authors.initials: X
authors.lastname: Bai
authors.affiliation: Department of Cardiac, The Fourth Affiliated Hospital of Harbin Medical University Harbin, China.
authors.forename: Xueqi
authors.initials: X
authors.lastname: Li
authors.affiliation: Department of Cardiac, The Fourth Affiliated Hospital of Harbin Medical University Harbin, China.
authors.forename: Hongyuan
authors.initials: H
authors.lastname: Xia
keywords: Recombinant human brain natriuretic peptide; contrast-induced nephropathy; coronary angiography; percutaneous coronary intervention